Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ITM + bupivacaine QLB is a combination analgesic regimen used primarily for postoperative pain management, especially after cesarean section and other abdominal surgeries. It combines intrathecal morphine (ITM), an opioid administered into the spinal fluid for long-lasting central analgesia, with a quadratus lumborum block (QLB) using the local anesthetic bupivacaine. The QLB is performed under ultrasound guidance to deliver bupivacaine near the quadratus lumborum muscle, providing regional anesthesia by blocking somatic and visceral nerve fibers in the abdominal wall. This multimodal approach aims to enhance pain relief while reducing systemic opioid requirements and their associated side effects[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ITM + bupivacaine QLB.